Voyageur Pharmaceuticals Ltd. (TSXV:VM)
0.1000
0.00 (0.00%)
May 12, 2026, 9:30 AM EST
Voyageur Pharmaceuticals Revenue
Voyageur Pharmaceuticals had revenue of 19.27K CAD in the quarter ending February 28, 2026. This brings the company's revenue in the last twelve months to 30.96K. In the fiscal year ending November 30, 2025, Voyageur Pharmaceuticals had annual revenue of 11.69K.
Revenue (ttm)
30.96K
Revenue Growth
n/a
P/S Ratio
579.72
Revenue / Employee
n/a
Employees
n/a
Market Cap
17.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Nov 30, 2025 | 11.69K | - | - |
| Nov 30, 2024 | - | - | - |
| Nov 30, 2023 | - | - | - |
| Nov 30, 2022 | - | - | - |
| Nov 30, 2021 | - | - | - |
| Nov 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ayr Wellness | 650.97M |
| 1CM Inc. | 75.04M |
| Red White & Bloom Brands | 64.83M |
| Medicure | 28.86M |
| Avicanna | 25.48M |
| Crescita Therapeutics | 21.12M |
| Greenway Greenhouse Cannabis | 9.13M |
| Red Light Holland | 4.17M |
Voyageur Pharmaceuticals News
- 11 days ago - Voyageur Announces Update To Non-Brokered Life Offering - TheNewswire
- 25 days ago - Voyageur Announces Shares for Debt Settlement and Stock Option Repricing - TheNewswire
- 6 weeks ago - Voyageur Announces Non-Brokered Life Offering - TheNewswire
- 2 months ago - Voyageur Announces Advancements on its Barium & Iodine Contrast Media Projects - TheNewswire
- 2 months ago - Voyageur Pharmaceuticals Confirms Pharmaceutical-Grade Purity of Barite from Frances Creek and Progresses to Health Canada Human Trial with Alberta Innovates Grant; Announces Stock Option and DSU grants, and Proposed Issuance of Securities for Debt - TheNewswire
- 2 months ago - Voyageur Pharmaceuticals Announces Collaboration with Bayer - TheNewswire
- 4 months ago - Voyageur Pharmaceuticals Strengthens Scientific Team by Adding Dr. Brian Mueller as Director of Chemistry and Secures Exclusive Ownership of Iodine Extraction Technology - TheNewswire
- 6 months ago - Voyageur Pharmaceuticals Ltd. Strengthens Board of Directors with Seasoned Financial Executive Virginia Alling to Drive U.S. Market Expansion - TheNewswire